Actively Recruiting
Standardized Procedure for Intracranial Drug-Eluting Stenting in the Treatment of Intracranial Atherosclerotic Stenosis
Led by Sino Medical Sciences Technology Inc. · Updated on 2025-04-01
300
Participants Needed
1
Research Sites
117 weeks
Total Duration
On this page
Sponsors
S
Sino Medical Sciences Technology Inc.
Lead Sponsor
T
The First Affiliated Hospital of Zhengzhou University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objective of this trial is to evaluate the Safety, Efficacy, and Standardized Procedural Optimization of the Intracranial Drug-Eluting Stent System in Patients with Symptomatic Intracranial Atherosclerotic Stenosis.
CONDITIONS
Official Title
Standardized Procedure for Intracranial Drug-Eluting Stenting in the Treatment of Intracranial Atherosclerotic Stenosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males or females between 18 and 80 years of age
- Symptomatic intracranial arteriosclerosis stenosis with reference diameter 2.25-4.00mm
- Intracranial artery stenosis (≥70%) confirmed by DSA
- Voluntarily willing to participate and sign informed consent
You will not qualify if you...
- Surgery within the previous 30 days or planned major surgery in the next 90 days (grade 3 or above)
- Acute hemorrhagic stroke within 3 months
- Baseline mRS score for disabling stroke greater than 3
- Target vessel severely calcified and closely related to stenosis
- Non-atherosclerotic diseases such as arterial dissection, Moya Moya disease, vascular inflammatory lesions, autoimmune diseases, post-irradiation, postpartum status, developmental or genetic abnormalities
- Ischemic event suspected to be due to embolism or cardiogenic embolism
- More than 50% stenosis in the main blood supply artery of the target vessel
- Presence of intracranial tumors or arteriovenous malformations
- Allergy to heparin, aspirin, clopidogrel, contrast agents, anesthetics, or stent components
- Pregnant or lactating women
- Unable to complete follow-up due to mental illness, cognitive or emotional disorders
- Investigator's judgment that the subject is not suitable for the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The first affiliated hospital of zhengzhou university
Zhengzhou, China
Actively Recruiting
Research Team
X
Xiaoyan Yu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here